4.4 Review

An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?

Related references

Note: Only part of the references are listed.
Review Medicine, Research & Experimental

Effects of the PPARγ agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus

K Nagashima et al.

JOURNAL OF CLINICAL INVESTIGATION (2005)